| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778167 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2018 | 5 Pages |
Abstract
CMA increases the diagnostic yield in fetuses with CHD, regardless of whether it is isolated or not. CMA should be the modality of choice when investigating the genetic origin of CHDs until whole exome or genome sequencing is implemented into routine clinical practice.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sifa Turan, Mehmet Resit Asoglu, Rinat Gabbay Benziv, Lauren Doyle, Christopher Harman, Ozhan M. Turan,